Claire Deligne

3PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 20, 2024
Half-Life Extension of the IgG-Degrading Enzyme (IdeS) Using Fc-Fusion Technology.

Victoria Daventure, Melissa Bou-Jaoudeh, Emna Hannachi

|May 14, 2021
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression.

Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz

|Jan 17, 2020
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.

Claire Deligne, Devadarssen Murdamoothoo, Anís N Gammage

Pageof 1